Interview: Alberto Wicker – CEO, Signufarma, Mexico

UntitledAlberto Wicker, CEO at Signufarma, explains how patient compliance programs can enhance the national healthcare system through reducing the cost of treatment as well as improving patients’ quality of life and showcases the added value of Signufarma’s business solutions to enhance the medical compliance of Mexican patients. Could you please introduce to our international audience the main activities and operations of Signufarma?
"For most chronic diseases patients will not take their medications for more than three months and, usually, those are lifetime treatments."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report